Inventor · disambiguated record
Rong Yang
Also filed as: YANG RONG · YANG RONG JIAN · YANG RONG-JIANG
40 granted patents·19 pending applications·94 citations·filing 2003–2024
97Inventor score
Files withADS THERAPEUTICS LLC15ALLERGAN INC14BRIGHAM & WOMENS HOSPITAL INC7CLOUDBREAK THERAPEUTICS LLC5CHILDRENS MEDICAL CENTER4
Top patents by PatentIndex Score
59 records- 0197US11191751B1Topical ophthalmological atropine free base compositionsADS THERAPEUTICS LLC·Filed 2021·Granted Dec 7, 2021·17 cites·12 claims
- 0295US10688092B2Compositions and methods of using nintedanib for improving glaucoma surgery successCLOUDBREAK THERAPEUTICS LLC·Filed 2019·Granted Jun 23, 2020·9 cites·27 claims
- 0394US12491183B2Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularizationADS THERAPEUTICS LLC·Filed 2024·Granted Dec 9, 2025·1 cites·13 claims
- 0492US12070501B1Topical ophthalmological compositionsADS THERAPEUTICS LLC·Filed 2022·Granted Aug 27, 2024·2 cites·15 claims
- 0591US11007214B2Compositions and methods for treating eye diseasesCLOUDBREAK THERAPEUTICS LLC·Filed 2020·Granted May 18, 2021·2 cites·10 claims
- 0690US12485177B2Topical ophthalmological compositionsADS THERAPEUTICS LLC·Filed 2024·Granted Dec 2, 2025·1 cites·14 claims
- 0790US11246864B2Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularizationADS THERAPEUTICS LLC·Filed 2017·Granted Feb 15, 2022·3 cites·10 claims
- 0890US10335408B2Compositions and methods of using nintedanib for improving glaucoma surgery successCLOUDBREAK THERAPEUTICS LLC·Filed 2018·Granted Jul 2, 2019·6 cites·27 claims
- 0990US8927747B214-hydroxy-docosahexaenoic acid compoundsSERHAN CHARLES N·Filed 2009·Granted Jan 6, 2015·11 cites·10 claims
- 1087US12156873B2Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the sameADS THERAPEUTICS LLC·Filed 2019·Granted Dec 3, 2024·2 cites·7 claims
- 1187US10233167B214-hydroxy-docosahexaenoic acid compoundsBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Mar 19, 2019·4 cites·5 claims
- 1287US9416118B2Docosahexaenoyl ethanolamidesSERHAN CHARLES N·Filed 2012·Granted Aug 16, 2016·6 cites·18 claims
- 1385US12214049B2Anti-angiogenic antibody-drug conjugatesADS THERAPEUTICS LLC·Filed 2020·Granted Feb 4, 2025·1 cites·15 claims
- 1484US11166977B2Compositions for treating meibomian gland dysfunctionADS THERAPEUTICS LLC·Filed 2020·Granted Nov 9, 2021·1 cites·2 claims
- 1582US10239850B214-hydroxy-docosahexaenoic acid compoundsBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Mar 26, 2019·2 cites·2 claims
- 1682US10233168B214-hydroxy-docosahexaenoic acid compoundsBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Mar 19, 2019·2 cites·3 claims
- 1782US9200016B2Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)ALLERGAN INC·Filed 2013·Granted Dec 1, 2015·3 cites·13 claims
- 1880US11110175B2Compositions with permeation enhancers for drug deliveryCHILDRENS MEDICAL CENTER·Filed 2016·Granted Sep 7, 2021·2 cites·26 claims
- 1980US10227291B2Docosahexaenoyl ethanolamidesBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Mar 12, 2019·1 cites·18 claims
- 2079US10123988B2Compositions including encapsulated isotretinoin and methods for use thereofALLERGAN INC·Filed 2014·Granted Nov 13, 2018·1 cites·6 claims
- 2179US9611239B214-hydroxy-docosahexaenoic acid compoundsBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted Apr 4, 2017·2 cites·32 claims
- 2279US9611238B214-hydroxy-docosahexaenoic acid compoundsBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted Apr 4, 2017·2 cites·15 claims
- 2378US11911379B2Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularizationADS THERAPEUTICS LLC·Filed 2022·Granted Feb 27, 2024·0 cites·22 claims
- 2477US10744153B1Compositions and methods for treating meibomian gland dysfunctionCLOUDBREAK THERAPEUTICS LLC·Filed 2019·Granted Aug 18, 2020·1 cites·12 claims
- 2577US9359336B2Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Jun 7, 2016·1 cites·8 claims
- 2677US2025161300A1Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the sameADS THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 2775US9611240B214-hydroxy-docosahexaenoic acid compoundsBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted Apr 4, 2017·1 cites·31 claims
- 2873US8168631B23-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activityLEBLOND BERTRAND·Filed 2009·Granted May 1, 2012·1 cites·21 claims
- 2972US8772316B2Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)LEBLOND BERTRAND·Filed 2012·Granted Jul 8, 2014·2 cites·20 claims
- 3071US7468391B2Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26BALLERGAN INC·Filed 2004·Granted Dec 23, 2008·5 cites·12 claims
- 3168US9598598B2Development of zwitterionic coatings that confer ultra anti-biofouling properties to commercial reverse osmosis membranesMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Granted Mar 21, 2017·2 cites·20 claims
- 3265US2023355594A1Topical ophthalmological compositionsADS THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 3363US2025115596A1Esters of 8-methyl-8-azabicyclo[3.2.1] octan-3-yl 3-hydroxy-2-phenylpropanoateADS THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 3462US10011593B2Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2017·Granted Jul 3, 2018·0 cites·5 claims
- 3561US12053527B2Compositions with permeation enhancers for drug deliveryCHILDRENS MEDICAL CENTER·Filed 2021·Granted Aug 6, 2024·0 cites·17 claims
- 3661US2019192467A1Compositions including encapsulated isotretinoin and methods for use thereofALLERGAN INC·Filed 2018·Application pending·0 cites
- 3759US9650366B2Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2016·Granted May 16, 2017·0 cites·2 claims
- 3857US10835617B2VEGF antibody-drug conjugatesNI JINSONG·Filed 2017·Granted Nov 17, 2020·0 cites·4 claims
- 3957US2023398233A1Ocular antibody-drug conjugatesADS THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4056US9296747B1Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2ALLERGAN INC·Filed 2014·Granted Mar 29, 2016·0 cites·5 claims
- 4156US2024216337A1Alpha2 adrenergic agonist codrugs conjugated with muscarinic agonist drugsADS THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 4254US10519326B2Antifouling and chlorine-resistant ultrathin coatings on reverse osmosis membranesGLEASON KAREN K·Filed 2014·Granted Dec 31, 2019·0 cites·11 claims
- 4354US9902710B2Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)ALLERGAN INC·Filed 2015·Granted Feb 27, 2018·0 cites·5 claims
- 4454US2004126384A1Combination of IgY against dental cariesFiled 2003·Application pending·0 cites
- 4554US2023210770A1Topical ophthalmological compositions and methods for treating abnormal angiogenesisADS THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4653US9670181B2Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)ALLERGAN INC·Filed 2014·Granted Jun 6, 2017·0 cites·10 claims
- 4753US2022331310A1Methods for alleviating pterygium-associated worry about eye appearanceCLOUDBREAK THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 4852US2011237495A1Functional metabolomics coupled microfluidic chemotaxis device and identification of novel cell mediatorsBRIGHAM & WOMENS HOSPITAL·Filed 2009·Application pending·0 cites
- 4952US2006198849A1Preparation method of igy for preventing and cure mouth disease and the toothpaste base on the igyPAAU SHING·Filed 2003·Application pending·0 cites
- 5048US11179388B2Topical composition for treating rosacea and a method for treating rosacea with the sameWHITCUP SCOTT·Filed 2018·Granted Nov 23, 2021·0 cites·5 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rong Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →